MVZ Sale
with the right multiple.
You lead an MVZ with 3-30 physicians. PE investors are calling. Multiples vary 5-13x EBITDA by specialty. We bring sector depth and §34d license for post-sale structuring to the sale process.
Multiple range 5-13x EBITDA
Naive multiples application leads to 12-22% over- or undervaluation. Sector (oncology/eye hot vs general moderate), KV-seat value (8-260 k€), physician retention contracts: three multiple drivers, all need quantification.
PEPP reform 2026
G-BA decisions Q1-Q2 2026 change OPS code valuation. Oncology + cardiology + specialty outpatient partially re-valued. Multiples range per sector may shift 8-12%. PEPP reform adjustment mandatory in every valuation.
Post-sale liquidity event
Liquidity event 5-25M € requires §34d license for post-sale structuring (family office, asset holding, foundations, succession). Cross-mandate synergy valuable.
MVZ Valuation Calculator
Indicative valuation in 90 seconds - Q2 2026 sector multiples
AME MVZ Sell-Side Stair-Step
EBITDA normalization, sector multiples range, KV-seat value audit, PEPP risk screen
Long/short list, IM, NDA wave, Q&A, bid-letter selection. 1.5-3.5% of transaction value
Term sheet, LOI, DD coordination, SPA negotiation, KV approval, closing, earn-out setup
How we work with MVZ leadership
Valuation audit (2-3 weeks)
EBITDA normalization - KV-seat audit - sector multiples range - PEPP reform adjustment - multi-scenario.
Bidder strategy (4-6 weeks)
Long/short list PE + strategic - NDA wave - discrete approach - IM - teaser distribution.
Negotiation (4-8 weeks)
Bid letter selection - LOI negotiation - DD coordination - SPA points - earn-out structure - KV approval prep.
Post-sale (ongoing)
Closing mechanics - earn-out monitoring - post-sale wealth structuring with §34d - succession planning.
MVZ leadership × other AME clusters
MVZ mandates cross healthcare + wealth + sometimes RE:
Sell-side process - PEPP reform adjustment - DD coordination
Post-sale structuring - §34d family office - succession
MVZ site sale vs practice sale - sale-and-lease-back
CSRD status as DD factor in MVZ groups
Common questions from MVZ leadership
Why AME STRATICON for MVZ sell-side?
§34d × M&A integrated
Marlies Machens §34d for post-sale - Bertram Engelhardt 20+ Jahre Healthcare-M&A - dual lead
Discrete bidder selection
PE roll-up platforms + strategic + HNWI co-invest - reverse-approach experience - NDA-first strategy
PEPP reform watch
Active G-BA decision monitoring - OPS code tracking - AMNOG updates - valuation adjustment models
Book MVZ Sell-Side Call
30 min with Bertram Engelhardt (M&A lead) or Marlies Machens (sector + post-sale §34d). Free pre-valuation via MVZ Valuation Calculator.
Book MVZ Sell-Side Call